Amgen Inc. (NASDAQ: AMGN) open the trading on December 22, 2020, with a bit cautious approach as it glided -2.78% to $220.99. During the day, the stock rose to $226.475 and sunk to $220.08 before settling in for the price of $227.31 at the close. Taking a more long-term approach, AMGN posted a 52-week range of $177.05-$264.97.
It was noted that the giant of the Healthcare sector posted annual sales growth of 3.10% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 14.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 2.00%. This publicly-traded company’s shares outstanding now amounts to $585.00 million, simultaneously with a float of $581.07 million. The organization now has a market capitalization sitting at $130.20 billion. At the time of writing, stock’s 50-day Moving Average stood at $228.37, while the 200-day Moving Average is $232.96.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 23400 workers. It has generated 994,060 per worker during the last fiscal year. Meanwhile, its income per employee was 335,128. The stock had 5.65 Receivables turnover and 0.37 Total Asset turnover. For the Profitability, stocks gross margin was +81.27, operating margin was +41.15 and Pretax Margin of +39.28.
Amgen Inc. (AMGN) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – General industry. Amgen Inc.’s current insider ownership accounts for 0.19%, in contrast to 78.10% institutional ownership. According to the most recent insider trade that took place on Nov 09, this organization’s Director sold 250 shares at the rate of 242.40, making the entire transaction reach 60,600 in total value, affecting insider ownership by 4,909. Preceding that transaction, on Aug 19, Company’s Director sold 1,000 for 241.02, making the whole transaction’s value amount to 241,020. This particular insider is now the holder of 15,589 in total.
Amgen Inc. (AMGN) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 9/29/2020 suggests? It has posted $4.37 earnings per share (EPS) beating the forecaster’s viewpoint (set at $3.81) by $0.56. This company achieved a net margin of +33.71 while generating a return on equity of 70.73. Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.21 per share during the current fiscal year.
Amgen Inc.’s EPS increase for this current 12-month fiscal period is 2.00% and is forecasted to reach 17.02 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 6.65% through the next 5 years, which can be compared against the 14.00% growth it accomplished over the previous five years trading on the market.
Amgen Inc. (NASDAQ: AMGN) Trading Performance Indicators
Let’s observe the current performance indicators for Amgen Inc. (AMGN). It’s Quick Ratio in the last reported quarter now stands at 1.90. The Stock has managed to achieve an average true range (ATR) of 4.46. Alongside those numbers, its PE Ratio stands at $17.82, and its Beta score is 0.76. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.21. Similarly, its price to free cash flow for trailing twelve months is now 19.87.
In the same vein, AMGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 12.40, a figure that is expected to reach 3.41 in the next quarter, and analysts are predicting that it will be 17.02 at the market close of one year from today.
Technical Analysis of Amgen Inc. (AMGN)
[Amgen Inc., AMGN] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 35.42% While, its Average True Range was 4.67.
Raw Stochastic average of Amgen Inc. (AMGN) in the period of the previous 100 days is set at 21.51%, which indicates a major rise in contrast to 7.51% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 17.49% that was lower than 28.15% volatility it exhibited in the past 100-days period.